TITLE:
Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis

CONDITION:
Ulcerative Colitis

INTERVENTION:
-aminosalicylic acid

SUMMARY:

      OBJECTIVES:

      I. Assess the safety and efficacy of 4-aminosalicylic acid in patients with mildly to
      moderately severe ulcerative colitis.
    

DETAILED DESCRIPTION:

      PROTOCOL OUTLINE: This is a randomized study. Patients are stratified by extent of disease.

      Patients are randomly assigned to oral 4-aminosalicylic acid (4-ASA) or placebo administered
      daily for 6 weeks. Optional 4-ASA is available to all patients for up to 1 year.

      Concurrent therapy with low-dose sulfasalazine, prednisone, or equivalent is allowed.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 80 Years
Criteria:

        PROTOCOL ENTRY CRITERIA:

          -  Mildly to moderately severe ulcerative colitis

          -  Patient age: 18 to 80
      
